Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

BRIEF-Sanofi and Regeneron say Praluent shows positive phase 3 trial data

By: Reuters: Company News
* Sanofi and Regeneron say Praluent shows positive investigational data in phase 3 trial Further company coverage: (Reporting by Laurence Frost)
Related Stocks:
Banco Santander ADR Regeneron Pharmaceuticals
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.